Grape Polyphenols (Whole Grape Extract)
Grape polyphenols are the mix of plant compounds found in grapes: anthocyanins (the red and purple pigments), flavanols, flavonols such as quercetin, and resveratrol. This page covers concentrated supplement forms: freeze-dried whole grape powder, grape and wine grape polyphenol extracts in capsules or tablets, and branded grape juice extracts such as Cognigrape. Fresh grapes, raisins and grape juice are covered on our grapes page, and grape seed extract has its own page. Most trials are small and short, and many were funded by the California Table Grape Commission or by extract makers. Grape powder lowered systolic blood pressure in one trial and triglycerides in two others; one grape extract ended with lower LDL cholesterol than placebo, while two other extract trials found no change in blood fats or blood pressure. Cognitive research rests mainly on two maker-linked trials of one branded extract.
Benefits
Systolic blood pressure
In 24 men with metabolic syndrome, a month of freeze-dried whole grape powder lowered systolic blood pressure versus placebo, in a trial funded by the California Table Grape Commission. Two extract trials found no change: wine grape polyphenol capsules in 35 healthy men and red grape extract tablets in a four-arm trial of 69 healthy adults. Pooled results for whole grapes, raisins and grape juice are on our grapes page.
Blood vessel function (flow-mediated dilation)
Flow-mediated dilation is an ultrasound test of how well an artery widens. In 24 men with metabolic syndrome, a month of freeze-dried grape powder raised it versus placebo. Other trials did not agree: wine grape polyphenol capsules had no effect in 35 healthy men, a month of grape powder changed few vascular markers in 20 adults with obesity, and a 30-trial meta-analysis found no overall effect on blood vessel function.
Blood triglycerides and LDL cholesterol
In a crossover trial in 44 women, 36 g/day of grape powder for 4 weeks lowered triglycerides (by 15% before and 6% after menopause) and LDL cholesterol. A 60 g/day trial in 20 adults with metabolic syndrome lowered triglycerides only. Extract trials were split: 700 mg/day of a grape extract ended with lower LDL and total cholesterol than placebo in 60 adults, while red grape extract tablets did not change them in 69 adults.
Memory and attention in older adults
Two placebo-controlled trials in healthy older adults (111 people, and 96 completers out of 120) tested the grape juice extract Cognigrape at 250 mg/day for 12 weeks and reported better scores on memory, attention and language tests. Both trials involved the extract's maker, they have not been repeated by an independent group, and the results apply to that extract rather than to grape products in general.
Brain glucose use on PET scans in older adults
In a pilot trial of 10 older adults with mild memory decline, funded by the California Table Grape Commission, brain scans after 6 months showed falling glucose use in some regions on placebo but stable use with freeze-dried whole grape powder. Memory and thinking test scores did not differ. A systematic review of grape trials on cognition, half using grape juice, found some improvements but designs varied too much to compare.
Markers of oxidative stress and inflammation
In a single-blind crossover trial in 44 women funded by the California Table Grape Commission, a urine marker of whole-body oxidative stress and the inflammatory signal TNF-alpha were lower after grape powder than after placebo, while LDL oxidation, IL-6 and CRP did not change. In 60 adults, a grape extract ended with higher plasma antioxidant capacity than placebo. These are lab markers, not health outcomes.
Mechanism of action
Nitric oxide and blood vessel relaxation
Nitric oxide signals artery walls to relax. In the 24-man grape powder trial, larger drops in systolic pressure went along with larger rises in blood nitrite and nitrate, a rough marker of nitric oxide, although average nitrite and nitrate levels did not differ from placebo.
Changes in how blood fats are carried
In the 44-woman trial, grape powder lowered apolipoproteins B and E, the proteins that carry LDL and other fat particles, and reduced the activity of cholesterol ester transfer protein by about 15%, an enzyme that moves cholesterol between lipoproteins.
Cell defense genes after a heavy meal
In 20 adults with obesity, taking grape powder with a high-fat, high-carbohydrate meal raised the activity of NRF2, a switch for the body's own antioxidant defense genes, in white blood cells and lowered endothelin-1, a vessel-narrowing signal, over the following hours versus placebo.
Clinical trials
Randomized, double-blind, placebo-controlled crossover trial of freeze-dried grape polyphenol powder for 30 days, with a 3-week washout. A companion report on the same men gives the dose (46 g/day, about 252 g of fresh grapes) and states that the senior author received funding from the California Table Grape Commission (Barona et al. 2012, J Nutr).
24 men aged 30 to 70 with metabolic syndrome, keeping their usual diet but avoiding polyphenol-rich foods.
Systolic blood pressure and the adhesion molecule sICAM-1 were lower, and flow-mediated dilation higher, during the grape period than the placebo period. Average nitrite and nitrate levels did not differ, and the other metabolic syndrome measures were unchanged. A small, short, grape-industry-funded trial.
Randomized, single-blind, placebo-controlled crossover trial of 36 g/day lyophilized (freeze-dried) whole grape powder, about 200 g of fresh grapes, or a sugar placebo matched for energy, 4 weeks each with a 3-week washout; supported by the California Table Grape Commission, which provided the powder, plus USDA Hatch and NIH grants (Zern et al. 2005, J Nutr)
44 women: 24 premenopausal and 20 postmenopausal.
Triglycerides fell 15% in premenopausal and 6% in postmenopausal women, and LDL cholesterol, apolipoproteins B and E and CETP activity were lower with grape powder. LDL oxidation did not change, while urinary F2-isoprostanes and plasma TNF-alpha fell; plasma IL-6 and CRP did not change. The powder was 92% carbohydrate.
Randomized, double-blind, placebo-controlled crossover pilot study of 60 g/day freeze-dried whole grape powder for 4 weeks, with a 3-week washout; the primary outcome was serum PON1 arylesterase activity, a measure of HDL antioxidant function; registered as NCT02542176 with the California Table Grape Commission as collaborator, and the Commission lists this study among those it funded (Millar et al. 2018, Metab Syndr Relat Disord)
20 adults aged 32 to 70 with metabolic syndrome.
The primary outcome, serum PON1 arylesterase activity, did not change, and neither did other HDL function markers. Fasting triglycerides fell versus placebo; other blood fats and metabolic measures did not change.
Randomized, double-blind, placebo-controlled crossover trial, three 2-week periods, testing capsules with 800 mg of polyphenols from a wine grape mix or from grape seed; the primary outcome was flow-mediated dilation (an ultrasound test of artery widening), with blood pressure, other vascular measures, platelet function and blood lipids as secondary outcomes; the first author was at Unilever Research and Development (van Mierlo et al. 2010, J Nutr)
35 healthy men.
The wine grape polyphenols did not change the primary outcome after a low-fat breakfast (difference versus placebo -0.4%, not significant), and the authors found no clear differences from placebo after a high-fat lunch or on any secondary outcome.
Randomized, placebo-controlled, double-blind crossover trial of 60 g freeze-dried whole grape powder (296 mg polyphenols), first with a single high-fat, high-carbohydrate meal and then daily for 4 weeks; registered as NCT01674231 with UC Davis as sponsor, and the California Table Grape Commission lists a whole grape powder study in obese individuals led by the senior author, Francene Steinberg, among those it funded (Bardagjy et al. 2018, Arch Biochem Biophys)
20 adults with obesity.
With the meal, grape powder raised NRF2 gene activity in white blood cells at 3 hours and lowered endothelin-1 at 5 hours versus placebo. After 4 weeks of daily use there was little effect on cardiovascular markers, apart from a rise in sVCAM-1, whose starting values differed between treatments.
Randomized, parallel, four-arm trial of red wine, red grape extract tablets at a wine-equivalent dose, the same tablets at half dose, or placebo tablets, for 4 weeks; outcomes were HDL and LDL cholesterol and their ratio, total cholesterol, VLDL triglycerides, fibrinogen, factor VII activity, blood pressure and body weight (Hansen et al. 2005, Eur J Clin Nutr)
69 healthy men and women aged 38 to 74.
Neither dose of red grape extract tablets had a significant effect on any of the measured outcomes compared with placebo. The changes seen with red wine appeared to come from its alcohol rather than from grape compounds.
Double-blind, placebo-controlled pilot study of a whole grape powder (described by the California Table Grape Commission, which lists it among its brain health studies, as equal to 2 1/4 cups of grapes a day) versus a polyphenol-free placebo powder for 6 months; the publisher funding record lists a California Table Grape Commission grant (11-002966) (Lee et al. 2017, Exp Gerontol)
10 older adults (average age 72) with mild decline in cognition.
PET scans showed falling glucose use in several brain regions in the placebo group and stable use in the grape group. Scores on memory and thinking tests did not differ between groups. Very small, and the scan result is a marker rather than a measure of daily function.
Randomized, double-blind, placebo-controlled trial of 700 mg/day of a polyphenol-rich grape extract (Eminol) for 56 days; the abstract reports end-of-study group values rather than changes from baseline, and the first author's affiliation was the research and development department of Esdor Cosméticos (Yubero et al. 2013, Int J Food Sci Nutr)
60 volunteers: 30 on the grape extract and 30 on placebo.
At the end of the study, total cholesterol (213.8 vs 245.6 mg/dL) and LDL cholesterol (142.2 vs 165.1 mg/dL) were lower, and plasma antioxidant capacity and vitamin E were higher, in the extract group than in the placebo group.
Randomized, double-blind, placebo-controlled trial of Cognigrape, a spray-dried red grape juice extract, at 250 mg/day for 12 weeks; two coauthors were at Bionap, the maker, although the paper declares no commercial or financial conflict (Calapai et al. 2017, Front Pharmacol)
111 healthy older adults aged 56 to 75 (57 extract, 54 placebo), mean age about 67.
Compared with placebo, MMSE and RBANS total scores improved, including attention, language, immediate memory and delayed memory; visuospatial and constructional abilities did not change. Beck Depression Inventory and Hamilton Anxiety scores also fell versus placebo. No adverse effects were detected.
Randomized, double-blind, placebo-controlled trial of 250 mg once daily of Cognigrape, a spray-dried red grape juice extract, for 84 days; funded by Bionap, the maker, with a Bionap employee as coauthor; of 120 people enrolled, the per-protocol group with complete data was analyzed, using one-tailed tests (Amone et al. 2024, Foods)
96 healthy older adults analyzed, of 120 enrolled.
Compared with placebo, the extract improved MMSE, RBANS, ENB-2 and Modified Bells Test scores, including immediate and delayed memory, visuospatial abilities, language and attention. Some gains appeared by day 14 and continued to day 84, and selective attention improved 90 minutes after the first dose.
Side effects and drug interactions
Common Potential side effects
Important Drug interactions
Frequently asked questions about Grape Polyphenols (Whole Grape Extract)
Is this the same as grape seed extract?
No. Grape seed extract is made from the seeds and is rich in proanthocyanidins, and its blood pressure trials are covered on our grape seed extract page. Whole grape and grape skin products also contain anthocyanins, the red and purple pigments of the skin, plus flavonols such as quercetin and resveratrol. Results from one type should not be assumed for the other.
Where do fresh grapes, raisins and grape juice fit in?
They are covered on our grapes page, which reviews trials of fresh grapes, raisins and 100% Concord grape juice as foods. This page covers concentrated forms sold as supplements: freeze-dried whole grape powder, grape polyphenol extracts in capsules or tablets, and branded juice extracts such as Cognigrape. Results from one form should not be assumed for another.
How much grape powder did the trials use?
Between 36 and 60 grams a day of freeze-dried powder for about 4 weeks, which in one trial matched roughly 252 g of fresh grapes. That is a food-sized serving, much larger than a capsule, and it is mostly sugar. In extract trials, 700 mg a day of one grape extract ended with lower LDL cholesterol than placebo, while capsules with 800 mg a day of wine grape polyphenols and red grape extract tablets found no clear change in blood fats.
What is Cognigrape?
Cognigrape is a branded, spray-dried extract of red grape juice, standardized to more than 9% proanthocyanidins and 4 to 5% anthocyanins. It is a concentrated grape juice extract rather than a seed extract, and it is the form behind most of the cognitive research on this page. See our Cognigrape page for its trials.
What is Grape Polyphenols?
Grape polyphenols are the mix of plant compounds found in grapes: anthocyanins (the red and purple pigments), flavanols, flavonols such as quercetin, and resveratrol.
What is Grape Polyphenols used for?
Grape Polyphenols is researched primarily for Cardiovascular, Cognitive, and Antioxidant. In 24 men with metabolic syndrome, a month of freeze-dried whole grape powder lowered systolic blood pressure versus placebo, in a trial funded by the California Table Grape Commission.
Is Grape Polyphenols safe, and does it have side effects?
Side effects and cautions reported for Grape Polyphenols include: In the 111-person Cognigrape trial, no adverse effects were detected over 12 weeks. The other trials cited here were small and short and were not designed to assess safety. It may also interact with some medications. Grape Polyphenols is not right for everyone, so check with a healthcare provider first if you are pregnant or breastfeeding, have a medical condition, or take prescription medication.
Does Grape Polyphenols interact with any medications?
Possible interactions include: No drug interaction studies of grape polyphenol supplements were found. If you take medicine for blood pressure, blood fats, blood sugar or blood clotting, check with a pharmacist or doctor before adding a concentrated grape extract. If you take prescription medication, check with a pharmacist or doctor before using it.
How strong is the scientific evidence for Grape Polyphenols?
NutraSmarts rates the evidence for Grape Polyphenols as Limited (2 out of 5). It is backed by 10 study summaries and 15 cited references summarized on this page. A higher rating reflects more, larger, and better-designed human studies.
References(15 citations)
Evidence ratings on NutraSmarts are based on the totality of human clinical research, with emphasis on randomized controlled trials, meta-analyses, and systematic reviews. The references below directly support claims made throughout this page.
- The effect of whole grape products on blood pressure and vascular function: A systematic review and meta-analysis of randomized controlled trials. Nutr Metab Cardiovasc Dis. 2023;33(10):1836-1848. doi: 10.1016/j.numecd.2023.05.001.PubMedUsed to support: Systematic review and meta-analysis of 30 randomized trials: grape products lowered systolic blood pressure by 3.17 mmHg on average (low certainty) and whole grape products (raisins and grape powder) by 2.69 mmHg, while grape juice did not. No significant effect on diastolic pressure, endothelial function, heart rate or sICAM-1; VCAM-1 rose slightly (very low certainty).
- Grape polyphenols reduce blood pressure and increase flow-mediated vasodilation in men with metabolic syndrome. J Nutr. 2012;142(9):1626-32. doi: 10.3945/jn.112.162743.PubMedUsed to support: Double-blind crossover trial in 24 men with metabolic syndrome: 30 days of freeze-dried grape polyphenol powder lowered systolic blood pressure and sICAM-1 and raised flow-mediated dilation versus placebo. Average nitrite and nitrate did not differ, but their changes correlated with systolic pressure changes. Other metabolic syndrome measures did not change.
- Grape consumption increases anti-inflammatory markers and upregulates peripheral nitric oxide synthase in the absence of dyslipidemias in men with metabolic syndrome. Nutrients. 2012;4(12):1945-57. doi: 10.3390/nu4121945.PubMedUsed to support: Second report from the same 24 men with metabolic syndrome: the dose was 46 g/day of lyophilized grape powder, about 252 g of fresh grapes, for 4 weeks. Adiponectin, IL-10 and iNOS expression rose versus placebo only in men without dyslipidemia. The senior author received funding from the California Table Grape Commission.
- Grape polyphenols exert a cardioprotective effect in pre- and postmenopausal women by lowering plasma lipids and reducing oxidative stress. J Nutr. 2005;135(8):1911-7. doi: 10.1093/jn/135.8.1911.PubMedUsed to support: Crossover trial in 24 premenopausal and 20 postmenopausal women: 36 g/day lyophilized grape powder for 4 weeks lowered triglycerides (15% and 6%), LDL cholesterol, apolipoproteins B and E and CETP activity (the placebo was an energy-matched fructose and dextrose mix), reduced urinary F2-isoprostanes and plasma TNF-alpha, and did not change LDL oxidation. The powder was 92% carbohydrate. The full text states that the California Table Grape Commission provided the powder and, with USDA Hatch and NIH grants, funded the study.
- Effects of Freeze-Dried Grape Powder on High-Density Lipoprotein Function in Adults with Metabolic Syndrome: A Randomized Controlled Pilot Study. Metab Syndr Relat Disord. 2018;16(9):464-469. doi: 10.1089/met.2018.0052.PubMedUsed to support: Double-blind crossover pilot trial in 20 adults with metabolic syndrome: 60 g/day freeze-dried grape powder for 4 weeks did not change HDL function (the primary outcome, PON1 activity) but lowered fasting triglycerides versus placebo; no other blood fat or metabolic changes. ClinicalTrials.gov (NCT02542176) lists the California Table Grape Commission as collaborator.
- Effects of grape consumption on biomarkers of inflammation, endothelial function, and PBMC gene expression in obese subjects. Arch Biochem Biophys. 2018;646:145-152. doi: 10.1016/j.abb.2018.04.003.PubMedUsed to support: Double-blind crossover trial in 20 adults with obesity: 60 g whole grape powder with a high-fat, high-carbohydrate meal raised NRF2 expression in blood cells and lowered endothelin-1 versus placebo; 4 weeks of daily use had little effect on cardiovascular biomarkers apart from a rise in sVCAM-1, whose baselines differed. ClinicalTrials.gov (NCT01674231) lists UC Davis as sponsor and 296 mg polyphenols per 60 g serving.
- Grape polyphenols do not affect vascular function in healthy men. J Nutr. 2010;140(10):1769-73. doi: 10.3945/jn.110.125518.PubMedUsed to support: Double-blind crossover trial in 35 healthy men, first author at Unilever R&D: 2 weeks of capsules with 800 mg polyphenols from a wine grape mix (or from grape seed) did not change flow-mediated dilation, and secondary outcomes including blood pressure, platelet function and blood fats showed no clear differences from placebo.
- Effect of red wine and red grape extract on blood lipids, haemostatic factors, and other risk factors for cardiovascular disease. Eur J Clin Nutr. 2005;59(3):449-55. doi: 10.1038/sj.ejcn.1602107.PubMedUsed to support: Four-arm parallel trial in 69 healthy adults: 4 weeks of red grape extract tablets (wine-equivalent or half dose) showed no treatment effect on LDL cholesterol, the HDL to LDL ratio, total cholesterol, VLDL triglycerides, factor VII activity or blood pressure; the HDL and fibrinogen changes with red wine appeared to be alcohol effects.
- LDL cholesterol-lowering effects of grape extract used as a dietary supplement on healthy volunteers. Int J Food Sci Nutr. 2013;64(4):400-6. doi: 10.3109/09637486.2012.753040.PubMedUsed to support: Double-blind trial in 60 volunteers: 700 mg/day of a polyphenol-rich grape extract (Eminol) for 56 days was followed by lower total and LDL cholesterol and higher antioxidant capacity and vitamin E than placebo. The abstract reports end-of-study group values rather than changes from baseline. The first author worked in the research and development department of a company, Esdor Cosméticos.
- Effects of grape products on blood lipids: a systematic review and dose-response meta-analysis of randomized controlled trials. Food Funct. 2019;10(10):6399-6416. doi: 10.1039/c9fo01248f.PubMedUsed to support: Dose-response meta-analysis of 48 randomized trials of grape products in any form: total cholesterol, LDL cholesterol and triglycerides fell slightly on average (about 6, 5 and 8 mg/dL), with no significant change in HDL. Pooled forms include products other than whole grape extracts.
- A Randomized, Double-Blinded, Clinical Trial on Effects of a Vitis vinifera Extract on Cognitive Function in Healthy Older Adults. Front Pharmacol. 2017;8:776. doi: 10.3389/fphar.2017.00776.PubMedUsed to support: Double-blind placebo-controlled trial in 111 healthy older adults: Cognigrape 250 mg/day for 12 weeks improved MMSE and RBANS scores, including attention, language and immediate and delayed memory, versus placebo; visuospatial skills did not change and no adverse effects were seen. Two authors were affiliated with the maker, Bionap, although the paper declares no conflict of interest.
- Standardized Grape (Vitis vinifera L.) Extract Improves Short- and Long-Term Cognitive Performances in Healthy Older Adults: A Randomized, Double-Blind, and Placebo-Controlled Trial. Foods. 2024;13(18):2999. doi: 10.3390/foods13182999.PubMedUsed to support: Double-blind placebo-controlled trial in 96 healthy older adults: the grape juice extract Cognigrape 250 mg once daily improved memory, attention, language and visuospatial test scores, with changes seen from day 14 to day 84. Bionap funded the trial and one author is a Bionap employee. Of 120 people randomized, the 96 who completed with good adherence were analyzed, using one-tailed tests.
- Examining the impact of grape consumption on brain metabolism and cognitive function in patients with mild decline in cognition: A double-blinded placebo controlled pilot study. Exp Gerontol. 2017;87(Pt A):121-128. doi: 10.1016/j.exger.2016.10.004.PubMedUsed to support: Double-blind, placebo-controlled pilot study in 10 older adults with mild cognitive decline: over 6 months, PET scans showed declining brain glucose metabolism in several regions on placebo but not with the grape formulation; neuropsychological test scores did not differ between groups. The publisher funding record lists a California Table Grape Commission grant (11-002966).
- The effect of grape interventions on cognitive and mental performance in healthy participants and those with mild cognitive impairment: a systematic review of randomized controlled trials. Nutr Rev. 2022;80(3):367-380. doi: 10.1093/nutrit/nuab025.PubMedUsed to support: Systematic review of 8 randomized trials of grape interventions (half of them grape juice, one grape seed extract) on cognition and mood in healthy adults and people with mild cognitive impairment: chronic studies found improvements in some cognitive domains and acute studies found faster reaction times but no clear memory effect; differences in design and dose hindered comparison.
- Funded Health Research Studies 1999-2022. California Table Grape Commission. 2022;As of October 2022 (accessed 2026)..SourceUsed to support: Not PubMed-indexed; grape-industry list of studies the Commission funded. It includes Maria Luz Fernandez's study of grape polyphenols in pre- and postmenopausal women (University of Connecticut), Christopher Blesso's study of freeze-dried grape powder on HDL function in metabolic syndrome, Francene Steinberg's whole grape powder study in obese individuals (UC Davis) and Daniel Silverman's grape powder brain metabolism study (UCLA).